These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9431355)

  • 1. [Low-dose ASA and infarct prophylaxis. Acetylsalicylic acid (ASA): low doses with high efficiency].
    Internist (Berl); 1995 Jan; 36(1 Suppl Low-dose-a):1-4. PubMed ID: 9431355
    [No Abstract]   [Full Text] [Related]  

  • 2. [The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].
    Tarján J; Salamon A; Jáger R; Poór F; Barczi V; Dinnyés J; Hamvas J; Kinczel A; Pál A; Blaskó G
    Orv Hetil; 1999 Oct; 140(42):2339-43. PubMed ID: 10560261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of acetylsalicylic acid in IHD].
    Lenkovsky F; Neirinck LG; Glezer SV
    Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin versus heparin in the acute phase of unstable angina.
    Moise A; Roos M
    Circulation; 1994 Aug; 90(2):1107. PubMed ID: 8044926
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
    Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal dosage of acetylsalicylic acid. I: Use in primary and secondary prevention of myocardial infarct and following aortocoronary bypass operation].
    Zichner R; Weihrauch TR
    Med Klin (Munich); 1989 Jan; 84(1):43-51. PubMed ID: 2645507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can patients without coronary heart disease prevent a heart infarct with 30 or 50 mg acetylsalicylic acid?].
    Schreiber M; Sechtem U
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2668. PubMed ID: 14673749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombotic therapy of unstable angina pectoris].
    Lassila R
    Duodecim; 1998; 114(15):1441, 1443-4. PubMed ID: 11552230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
    Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin for prevention of myocardial infarction. A double-edged sword.
    Bar-Dayan Y; Levy Y; Amital H; Shoenfeld Y
    Ann Med Interne (Paris); 1997; 148(6):430-3. PubMed ID: 9538376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet aggregation inhibitor in general practice. Every 3rd infarct prevented--reinfarction rate cut in half].
    Fliri M
    MMW Fortschr Med; 2002 Aug; 144(33-34):38-41. PubMed ID: 12380142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two years follow-up Cottbus reinfarction study with 30 and 60 mg acetylsalicylic acid.
    Hoffmann W; Förster W
    Prog Clin Biol Res; 1987; 242():393-7. PubMed ID: 3671392
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
    Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):27-37. PubMed ID: 12852481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What are the recommendations for acute therapy of myocardial infarct with acetylsalicylic acid and heparin, which analgesics should be prescribed?].
    Internist (Berl); 1995 Jun; 36(6):617. PubMed ID: 7665333
    [No Abstract]   [Full Text] [Related]  

  • 17. Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: data from the 1995 population-based Nova Scotia Health Survey.
    Rojas-Fernandez CH; Kephart GC; Sketris IS; Kass K
    Can J Cardiol; 1999 Mar; 15(3):291-6. PubMed ID: 10202192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugs].
    Reuther LØ; Andersen SE
    Ugeskr Laeger; 2006 Mar; 168(13):1310-4. PubMed ID: 16579883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness analysis of prevention of reinfarction using low-dose acetylsalicylic acid; model calculation].
    Schädlich PK; Brecht JG
    Soz Praventivmed; 1997; 42(2):114-20. PubMed ID: 9221624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin.
    Theroux P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):799. PubMed ID: 12497824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.